Haleon plc
Health
Performance
1.7
Risk
Sell
Buy
Curious about the Scores? Learn more.

Haleon plc stock rating and score history

All changes in ratings, performance and outlook tracked over time.

10.02.2026
Slowing down. Might be a breather – or a shift.
06.02.2026
From average to promising. Starting to shine again.
28.01.2026
Rock solid. Minimal risk, max control.
20.08.2025
Climbing out. Risks fading, but not out of the woods.
HLN
Low-poly 3D Haleon (HLN) stock icon with a stylized pill capsule, symbolizing healthcare and biotech.
11.04
+1.47%
1.7
Sell
Buy
Haleon plc

Haleon plc stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Haleon plc do? Business model and key facts

Get the full picture of Haleon plc: what it builds, where it operates, and how it makes money.

Haleon plc Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 24561

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

shop
Company facts
Brian James McNamara
CEO
24561
Employees worldwide
shop
Performance
12.4%
Last 12 months
45.07%
Last 5 years
shop
Growth
$11,23B
Revenue year
$1,44B
Net income
shop
Valuation
$49,75B
Market Cap
23.89
Price/Earnings Ratio

Stocks related to Haleon plc

Selected based on industry alignment and relative market positioning.

MRK.DE
Merck KGaA
123.30
+1.52%
3.4
Sell
Buy
Merck KGaA
ZTS
Low-poly 3D Zoetis (ZTS) stock icon with a stylized paw print, symbolizing industrials.
128.13
+0.65%
5.9
Sell
Buy
Zoetis Inc.
TAK
Takeda Pharmaceutical Company Limited
18.10
+2.09%
2.4
Sell
Buy
Takeda Pharmaceutical Company Limited
TEVA
Teva Pharmaceutical Industries Limited
34.37
-0.29%
5.7
Sell
Buy
Teva Pharmaceutical Industries Limited
VTRS
Viatris Inc.
15.95
+2.51%
3.9
Sell
Buy
Viatris Inc.

Haleon plc fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.